Patents by Inventor Amanda M. Burkhardt

Amanda M. Burkhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF A NOVEL B CELL CYTOKINE
    Publication number: 20200087368
    Abstract: Compositions and methods involving IL40, a novel cytokine produced by activated B cells, are provided. The compositions include: a) anti-IL40 antibodies, IL40 peptides and IL40 proteins; b) nucleic acids encoding IL40 gene and cDNA sequences; and c) pharmaceutical compositions thereof. The methods include treatments, diagnostics and isolation technologies.
    Type: Application
    Filed: November 21, 2019
    Publication date: March 19, 2020
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Albert Zlotnik, Peter Hevezi, Van Phi Luu, Amanda M. Burkhardt, Irina Ushach
  • IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR
    Publication number: 20160368995
    Abstract: Method of treating a subject for a disorder that correlates to increased CXCR8 signaling. The method includes disrupting the activation of receptor CXCR8 by ligand CXCL17 in the subject. In the method, the disrupting can include administering to the subject a substance that interferes with CXCL17 binding to CXCR8. Methods of screening, ligands, agonists, antagonists and vaccines involving the CXCR8/CXCL17 axis are also provided.
    Type: Application
    Filed: September 30, 2014
    Publication date: December 22, 2016
    Applicant: The Regents of the University of California
    Inventors: Albert Zlotnik, Jose L. Maravillasmontero, Amanda M. Burkhardt
  • IDENTIFICATION OF A NOVEL B CELL CYTOKINE
    Publication number: 20160297860
    Abstract: Compositions and methods involving IL40, a novel cytokine produced by activated B cells, are provided. The compositions include: a) anti-IL40 antibodies, IL40 peptides and IL40 proteins; b) nucleic acids encoding IL40 gene and cDNA sequences; and c) pharmaceutical compositions thereof. The methods include treatments, diagnostics and isolation technologies.
    Type: Application
    Filed: November 20, 2014
    Publication date: October 13, 2016
    Applicant: The Regents of the University of California
    Inventors: Albert Zlotnik, Peter Hevezi, Van Phi Luu, Amanda M. Burkhardt, Irina Ushach
  • USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE
    Publication number: 20150140008
    Abstract: A method of treating a disease associated with increased levels of chemokine CXCL17. The method includes administering to a subject in need of such treatment a therapeutically effective amount of a substance that lowers the level of CXCL17 activity. The substance can be a CXCL17 antibody, or an antisense compound targeting CXCL17 such as an antisense oligonucleotide or an siRNA. Also provided are methods of treating tumors with CXCL17 and methods of diagnosing a disease associated with increased levels of CXCL17.
    Type: Application
    Filed: May 3, 2013
    Publication date: May 21, 2015
    Applicant: The Regents of the University of California
    Inventors: Albert Zlotnik, Amanda M. Burkhardt